Cargando…

Drug repurposing using meta-analysis of gene expression in Alzheimer’s disease

INTRODUCTION: Alzheimer’s disease and other forms of dementia are disease that bring an increased global burden. However, the medicine developed to date remains limited. The purpose of this study is to predict drug repositioning candidates using a computational method that integrates gene expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Ha Young, Oh, Jung Mi, Kim, In-Wha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684643/ https://www.ncbi.nlm.nih.gov/pubmed/36440278 http://dx.doi.org/10.3389/fnins.2022.989174

Ejemplares similares

Meta-Analysis of Gene Expression and Identification of Biological Regulatory Mechanisms in Alzheimer's Disease
por: Su, Lining, et al.
Publicado: (2019)

Uncovering neuroinflammation-related modules and potential repurposing drugs for Alzheimer's disease through multi-omics data integrative analysis
por: Li, Shensuo, et al.
Publicado: (2023)

Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease
por: Mukerjee, Nobendu, et al.
Publicado: (2022)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

Comparative Safety Analysis of Empagliflozin in Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease versus Normal Kidney Function: A Nationwide Cohort Study in Korea
por: Jang, Ha Young, et al.
Publicado: (2023)

Relationship Between Alzheimer’s Disease and the Immune System: A Meta-Analysis of Differentially Expressed Genes
por: Wang, Nan, et al.
Publicado: (2019)

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
por: Jung, Yoo Jin, et al.
Publicado: (2021)

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
por: Stott, Simon R. W., et al.
Publicado: (2021)

Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing Perspective
por: Lötsch, Jörn, et al.
Publicado: (2017)

Drug Repurposing in the Treatment of Traumatic Brain Injury
por: Ghiam, Michael K., et al.
Publicado: (2021)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2020)

Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Single-cell-led drug repurposing for Alzheimer’s disease
por: Parolo, Silvia, et al.
Publicado: (2023)

Modeling Path Importance for Effective Alzheimer’s Disease Drug Repurposing
por: Xiang, Shunian, et al.
Publicado: (2023)

RETRACTED ARTICLE: Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles
por: Kim, In-Wha, et al.
Publicado: (2019)

Retraction Note: Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles
por: Kim, In-Wha, et al.
Publicado: (2022)

Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information
por: Jang, Ha Young, et al.
Publicado: (2022)

Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease
por: Lee, Wha Jin, et al.
Publicado: (2021)

Identification of Potential Repurposable Drugs in Alzheimer’s Disease Exploiting a Bioinformatics Analysis
por: Fiscon, Giulia, et al.
Publicado: (2022)

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
por: Yarchoan, Mark, et al.
Publicado: (2014)

Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Rodriguez, Steve, et al.
Publicado: (2021)

Network-based stage-specific drug repurposing for Alzheimer’s disease
por: Savva, Kyriaki, et al.
Publicado: (2022)

Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Repurposing of Tibolone in Alzheimer’s Disease
por: Barreto, George E.
Publicado: (2023)

Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study
por: Jang, Ha Young, et al.
Publicado: (2022)

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
por: Jang, Ha Young, et al.
Publicado: (2022)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Systematic identification of risk factors and drug repurposing options for Alzheimer's disease
por: Wu, Chong, et al.
Publicado: (2021)

Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network
por: Soleimani Zakeri, Negar Sadat, et al.
Publicado: (2021)

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood
por: Bourdakou, Marilena M., et al.
Publicado: (2023)

Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson’s disease
por: Greco, Marco, et al.
Publicado: (2023)

Drug repurposing in psoriasis, performed by reversal of disease-associated gene expression profiles
por: Ahmed, Faheem, et al.
Publicado: (2022)

Co-expression Network Analysis Reveals Novel Genes Underlying Alzheimer’s Disease Pathogenesis
por: Hu, Rui-ting, et al.
Publicado: (2020)

Gene expression‐based drug repurposing to target aging
por: Dönertaş, Handan Melike, et al.
Publicado: (2018)

Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis
por: Pan, Xiongfeng, et al.
Publicado: (2020)

Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
por: Carboni, Ezio, et al.
Publicado: (2021)

Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?
por: Lordén, Gema, et al.
Publicado: (2021)

Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing
por: Hsieh, Kang-Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ap3nhf5rcuhtobstfgd8cm5c64